Sendai virus-based RSV vaccine protects African green monkeys from RSV infection.
about
A respiratory syncytial virus (RSV) vaccine based on parainfluenza virus 5 (PIV5).Sendai virus-based RSV vaccine protects against RSV challenge in an in vivo maternal antibody model.Mucosal vaccines against respiratory syncytial virusSafety and immunogenicity of an intranasal Sendai virus-based human parainfluenza virus type 1 vaccine in 3- to 6-year-old children.Relationships among dissemination of primary parainfluenza virus infection in the respiratory tract, mucosal and peripheral immune responses, and protection from reinfection: a noninvasive bioluminescence-imaging studyThe Pneumonia Virus of Mice (PVM) model of acute respiratory infection.Respiratory nanoparticle-based vaccines and challenges associated with animal models and translationLive-attenuated respiratory syncytial virus vaccines.Influence of antigen insertion site and vector dose on immunogenicity and protective capacity in Sendai virus-based human parainfluenza virus type 3 vaccines.Sendai virus as a backbone for vaccines against RSV and other human paramyxovirusesRecent advances in diagnosis, prevention, and treatment of human respiratory syncytial virus.Novel vaccine regimen elicits strong airway immune responses and control of respiratory syncytial virus in nonhuman primates.Recent developments with live-attenuated recombinant paramyxovirus vaccines.Respiratory syncytial virus: current progress in vaccine development.Advances in and the potential of vaccines for respiratory syncytial virus.RNA-based viral vectors.Novel therapies and vaccines against the human respiratory syncytial virus.Respiratory syncytial virus vaccines: an update on those in the immediate pipeline.Viral and Synthetic RNA Vector Technologies and Applications.Animal models of respiratory syncytial virus infection.Sendai virus recombinant vaccine expressing a secreted, unconstrained respiratory syncytial virus fusion protein protects against RSV in cotton rats.Soluble F proteins exacerbate pulmonary histopathology after vaccination upon respiratory syncytial virus challenge but not when presented on virus-like particles.A Sendai virus recombinant vaccine expressing a gene for truncated human metapneumovirus (hMPV) fusion protein protects cotton rats from hMPV challenge.Perinatal lamb model of respiratory syncytial virus (RSV) infection.Sendai Virus Mucosal Vaccination Establishes Lung-Resident Memory CD8 T Cell Immunity and Boosts BCG-Primed Protection against TB in Mice.A Respiratory Syncytial Virus Vaccine Vectored by a Stable Chimeric and Replication-Deficient Sendai Virus Protects Mice without Inducing Enhanced Disease.Inhibition of primary clinical isolates of human parainfluenza virus by DAS181 in cell culture and in a cotton rat model.Detection of respiratory syncytial virus fusion protein variants between 2009 and 2012 in China.Respiratory syncytial virus (RSV) pneumonia in a southern muriqui (Brachyteles arachnoides).Vaccines for the Paramyxoviruses and Pneumoviruses: Successes, Candidates, and Hurdles.
P2860
Q33690612-AB4912F0-1DF9-4532-9DD6-0904735506F7Q33724997-D5AF2081-9794-4C59-AEC3-A4AE8F9C1612Q33837530-9BD6B13F-1D22-4AFD-AA22-08D59B13E4CDQ35122827-FEFF3449-EBAC-483E-8C7B-F6B93A7F4054Q35487966-3A37E24B-C620-4FB0-BA93-886BC4C76F26Q36482753-FC95F1B9-DD67-4534-9030-0FE1124AC4A7Q36598433-003B57FD-709B-4DFE-BFE9-24610C4FF99AQ36692801-0413ECF7-5B8E-429E-9037-A58752BF4302Q36827280-977D314F-B776-4815-BCD3-BD7B310A7787Q37118707-F8EFE3C6-01EC-41C8-A9E7-C0B49195052BQ37412509-C4B1378C-843D-4CC1-981A-E54B067AC3B3Q37713895-C3CAAA42-3A3F-4027-9C44-94E31F47E8EEQ38008607-BDC66ED1-C3D5-4326-A185-4F9265EFF332Q38079432-2C3BA35B-58DA-4EEA-B9FD-894BEEAB7EF0Q38130514-C743E16C-64EC-4211-BDD1-86318FEC666CQ38266413-371913A3-4610-48D0-973E-0AFB4055D834Q38604787-00350759-EA65-44EC-BB4A-0FA5E9101BDAQ38803541-2D3B08F4-345B-4DEE-928A-5A74E30BF83BQ38885624-7BACAD39-144D-49DC-B6FE-E64EF391A54CQ39026362-54F0735B-9579-4B06-B2A3-BCAA659C4413Q39868227-32A95D51-B556-4C80-BA81-E6B495C24E5AQ40065136-D8CFCBB6-66B2-419D-B735-BCC22A80AD5DQ40163240-D429AFCB-8114-40C2-9A90-7D5CFAD7532BQ40266020-5B1010A5-2DC6-4D21-BA61-340B445C197DQ40273775-2E9757AE-001C-4B21-AD32-13C362BD560BQ40312271-17DFAFFB-C960-4C1C-A3AB-CFC804781808Q41873413-9723D2D5-BA29-41B9-A50D-F3C15ABCFA77Q42251545-F6AFA435-076D-4F73-81DF-C52CADF32C2DQ43560767-5B098B5D-63B1-40E3-BC70-BBD04A2568AFQ47555408-E3D026F9-EA05-46B2-9B5D-FDDC4118E558
P2860
Sendai virus-based RSV vaccine protects African green monkeys from RSV infection.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Sendai virus-based RSV vaccine protects African green monkeys from RSV infection.
@ast
Sendai virus-based RSV vaccine protects African green monkeys from RSV infection.
@en
type
label
Sendai virus-based RSV vaccine protects African green monkeys from RSV infection.
@ast
Sendai virus-based RSV vaccine protects African green monkeys from RSV infection.
@en
prefLabel
Sendai virus-based RSV vaccine protects African green monkeys from RSV infection.
@ast
Sendai virus-based RSV vaccine protects African green monkeys from RSV infection.
@en
P2093
P2860
P1433
P1476
Sendai virus-based RSV vaccine protects African green monkeys from RSV infection.
@en
P2093
Allen Portner
Anthony Cook
Bart G Jones
Brad Finneyfrock
Julia L Hurwitz
Rajeev Rudraraju
Robert E Sealy
Toru Takimoto
Vicki L Traina-Dorge
P2860
P304
P356
10.1016/J.VACCINE.2011.11.046
P407
P577
2011-11-23T00:00:00Z